You searched for Antibody candidate - Page 65 of 67

News and Trends 12 Dec 2022

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

…to its dual mode of action comprising both antibody-dependent cellular phagocytosis induction and IL-7R-pathway blockade, OSE-127 may represent a promising novel immunotherapy option for ALL patients, including cases with dysregulated…

December 12, 2022 - 4 minutesmins - By Jim Cornall

Interview 6 Mar 2017

How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains

…use bicyclic peptides to guide toxins in an approach similar to antibody-drug conjugates (ADCs); and they stand to outperform their antibody-guided counterparts. Kevin Lee, CEO of Bicycle Therapeutics, sat down…

March 6, 2017 - 7 minutesmins - By Evelyn Warner

News and Trends 29 May 2020

Argenx Follows up Phase III Success with Giant €785M Global Offering

…III trial results earlier this week, where its lead candidate antibody drug, efgartigimod, improved motor symptoms of patients with the chronic autoimmune disease myasthenia gravis. Argenx is listed on the…

May 29, 2020 - 2 minutesmins - By Jonathan Smith

Best in Biotech 26 Dec 2017

Interviews, Reviews and Tops: Our Best Biotech Articles from 2017

…of approaches… https://www.labiotech.eu/tag/mrna-technology/ RNA saw its first major win in perhaps decades this year, with the positive Phase III results for Alnylam and Sanofi‘s candidate, patisiran. So how far has…

December 26, 2017 - 6 minutesmins - By Evelyn Warner

biotech investment asia pacific june 2022

In Depth 19 Jul 2022

The biggest Asia-Pacific biotech investments in June 2022

…using artificial intelligence (AI) and robotics to automate many research techniques including antibody selection, cell line development and molecular screening. “The global life sciences automation industry has significant growth potential,”…

July 19, 2022 - 3 minutesmins - By Jonathan Smith

Best in Biotech 7 Jan 2019

15 European Biotech Companies to Watch in 2019

…by its IPO, Orchard is planning to complete clinical development for its three lead gene therapy candidates and hopefully get them to the market. The company will also be pushing…

January 7, 2019 - 9 minutesmins - By Clara Rodríguez Fernández

More News! 3 Apr 2019

€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies

The Belgian biotech AgomAb has raised €21M and partnered with the Dutch biotech argenx to develop antibody treatments that could regenerate damaged tissue. The round was led by the Belgian…

April 3, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 4 Sep 2018

The EMA Approves the First Nanobody from Ablynx

…nanobody — a single-domain antibody inspired by those of llamas and camels that combines the specificity of a full antibody with the advantages of having a significantly smaller size. After…

September 4, 2018 - 2 minutesmins - By Editorial Team

In Depth 13 Jul 2022

The biggest European biotech investments in June 2022

…million) in a Series C round to finance the development of antibody drugs that fight cancer by recruiting a type of immune cell called gamma delta T cells. “In a…

July 13, 2022 - 3 minutesmins - By Jonathan Smith

In Depth 27 Jun 2024

The 2024 drug approval list: Eight new treatments you should know about

…apart from Rytelo and Anktiva, the FDA greenlit Amgen’s T-cell engager Imdelltra for small-cell lung cancer and BeiGene’s monoclonal antibody Tevimbra for esophageal squamous cell carcinoma this year. Later this…

June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 5 Jul 2022

Brii Bio takes hepatitis B treatment option

…collaboration with Vir Biotechnology, Inc. VIR-3434, also known as BRII-877, is a broadly neutralizing monoclonal antibody targeting hepatitis B virus (HBV) that is currently in phase 2 development. This is…

July 5, 2022 - 3 minutesmins - By Jim Cornall

In Depth 1 Oct 2018

Could These Innovative Flu Vaccines Prevent Deaths From Deadly Outbreaks?

…this vaccine could come to market within the decade, as it works by stimulating the body’s antibody response in a conventional manner and so licensing regulations should be less strict….

October 1, 2018 - 8 minutesmins - By David Cox

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains

Argenx Follows up Phase III Success with Giant €785M Global Offering

Interviews, Reviews and Tops: Our Best Biotech Articles from 2017

The biggest Asia-Pacific biotech investments in June 2022

15 European Biotech Companies to Watch in 2019

€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies

The EMA Approves the First Nanobody from Ablynx

The biggest European biotech investments in June 2022

The 2024 drug approval list: Eight new treatments you should know about

Brii Bio takes hepatitis B treatment option

Could These Innovative Flu Vaccines Prevent Deaths From Deadly Outbreaks?

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!